BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern

Cristiane M. Ida, Sally R. Lambert, Fausto J. Rodriguez, Jesse S. Voss, Brooke E. Mc Cann, Amber R. Seys, Kevin C. Halling, V. Peter Collins, Caterina Giannini

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Cerebellar low-grade astrocytomas with a diffuse pattern of growth are uncommon, comprising World Health Organization (WHO) grade II diffuse astrocytomas (DA) and a minority of WHO grade I pilocytic astrocytomas (PA), so-called PA, "diffuse variant." Among 106 cerebellar low-grade astrocytomas (WHO grade I and II) operated on at the Mayo Clinic (1984-2010), we identified 19 such cases: 8 PA, "diffuse variant," 5 DA, and 6 that we were unable to classify further (low-grade astrocytomas, subtype indeterminate). We characterized these tumors using immunohistochemistry and currently available molecular markers (IDH1/2 mutations and BRAF mutation/fusion gene status) and investigated whether the markers could be used to aid the diagnostic process in combination with the clinical and pathologic features. KIAA1549-BRAF fusion was detected in 4 PA, "diffuse variant," 2 DA, and 2 low-grade astrocytomas, subtype indeterminate, indicating that these tumors were molecularly consistent with PA, the most common subtype of the series. A BRAF V600E mutation was detected in 1 PA, "diffuse variant" case; an IDH1 R132G mutation was found in 1 DA case. These results suggest that KIAA1549-BRAF fusion status and IDH1/2 and BRAF V600E mutational analyses may assist in the histologic classification of this diagnostically challenging group of tumors and result in a more accurate and objective combined molecular and histologic classification.

Original languageEnglish (US)
Pages (from-to)631-639
Number of pages9
JournalJournal of Neuropathology and Experimental Neurology
Volume71
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Astrocytoma
Growth
Mutation
Minority Health
Neoplasms
Gene Fusion

Keywords

  • BRAF
  • Cerebellar astrocytoma
  • Diffuse
  • IDH1
  • IDH2
  • Low grade
  • Pilocytic

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern. / Ida, Cristiane M.; Lambert, Sally R.; Rodriguez, Fausto J.; Voss, Jesse S.; Mc Cann, Brooke E.; Seys, Amber R.; Halling, Kevin C.; Collins, V. Peter; Giannini, Caterina.

In: Journal of Neuropathology and Experimental Neurology, Vol. 71, No. 7, 07.2012, p. 631-639.

Research output: Contribution to journalArticle

Ida, CM, Lambert, SR, Rodriguez, FJ, Voss, JS, Mc Cann, BE, Seys, AR, Halling, KC, Collins, VP & Giannini, C 2012, 'BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern', Journal of Neuropathology and Experimental Neurology, vol. 71, no. 7, pp. 631-639. https://doi.org/10.1097/NEN.0b013e31825c448a
Ida, Cristiane M. ; Lambert, Sally R. ; Rodriguez, Fausto J. ; Voss, Jesse S. ; Mc Cann, Brooke E. ; Seys, Amber R. ; Halling, Kevin C. ; Collins, V. Peter ; Giannini, Caterina. / BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern. In: Journal of Neuropathology and Experimental Neurology. 2012 ; Vol. 71, No. 7. pp. 631-639.
@article{07e6b84e468848738f69dd7deaa117d8,
title = "BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern",
abstract = "Cerebellar low-grade astrocytomas with a diffuse pattern of growth are uncommon, comprising World Health Organization (WHO) grade II diffuse astrocytomas (DA) and a minority of WHO grade I pilocytic astrocytomas (PA), so-called PA, {"}diffuse variant.{"} Among 106 cerebellar low-grade astrocytomas (WHO grade I and II) operated on at the Mayo Clinic (1984-2010), we identified 19 such cases: 8 PA, {"}diffuse variant,{"} 5 DA, and 6 that we were unable to classify further (low-grade astrocytomas, subtype indeterminate). We characterized these tumors using immunohistochemistry and currently available molecular markers (IDH1/2 mutations and BRAF mutation/fusion gene status) and investigated whether the markers could be used to aid the diagnostic process in combination with the clinical and pathologic features. KIAA1549-BRAF fusion was detected in 4 PA, {"}diffuse variant,{"} 2 DA, and 2 low-grade astrocytomas, subtype indeterminate, indicating that these tumors were molecularly consistent with PA, the most common subtype of the series. A BRAF V600E mutation was detected in 1 PA, {"}diffuse variant{"} case; an IDH1 R132G mutation was found in 1 DA case. These results suggest that KIAA1549-BRAF fusion status and IDH1/2 and BRAF V600E mutational analyses may assist in the histologic classification of this diagnostically challenging group of tumors and result in a more accurate and objective combined molecular and histologic classification.",
keywords = "BRAF, Cerebellar astrocytoma, Diffuse, IDH1, IDH2, Low grade, Pilocytic",
author = "Ida, {Cristiane M.} and Lambert, {Sally R.} and Rodriguez, {Fausto J.} and Voss, {Jesse S.} and {Mc Cann}, {Brooke E.} and Seys, {Amber R.} and Halling, {Kevin C.} and Collins, {V. Peter} and Caterina Giannini",
year = "2012",
month = "7",
doi = "10.1097/NEN.0b013e31825c448a",
language = "English (US)",
volume = "71",
pages = "631--639",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern

AU - Ida, Cristiane M.

AU - Lambert, Sally R.

AU - Rodriguez, Fausto J.

AU - Voss, Jesse S.

AU - Mc Cann, Brooke E.

AU - Seys, Amber R.

AU - Halling, Kevin C.

AU - Collins, V. Peter

AU - Giannini, Caterina

PY - 2012/7

Y1 - 2012/7

N2 - Cerebellar low-grade astrocytomas with a diffuse pattern of growth are uncommon, comprising World Health Organization (WHO) grade II diffuse astrocytomas (DA) and a minority of WHO grade I pilocytic astrocytomas (PA), so-called PA, "diffuse variant." Among 106 cerebellar low-grade astrocytomas (WHO grade I and II) operated on at the Mayo Clinic (1984-2010), we identified 19 such cases: 8 PA, "diffuse variant," 5 DA, and 6 that we were unable to classify further (low-grade astrocytomas, subtype indeterminate). We characterized these tumors using immunohistochemistry and currently available molecular markers (IDH1/2 mutations and BRAF mutation/fusion gene status) and investigated whether the markers could be used to aid the diagnostic process in combination with the clinical and pathologic features. KIAA1549-BRAF fusion was detected in 4 PA, "diffuse variant," 2 DA, and 2 low-grade astrocytomas, subtype indeterminate, indicating that these tumors were molecularly consistent with PA, the most common subtype of the series. A BRAF V600E mutation was detected in 1 PA, "diffuse variant" case; an IDH1 R132G mutation was found in 1 DA case. These results suggest that KIAA1549-BRAF fusion status and IDH1/2 and BRAF V600E mutational analyses may assist in the histologic classification of this diagnostically challenging group of tumors and result in a more accurate and objective combined molecular and histologic classification.

AB - Cerebellar low-grade astrocytomas with a diffuse pattern of growth are uncommon, comprising World Health Organization (WHO) grade II diffuse astrocytomas (DA) and a minority of WHO grade I pilocytic astrocytomas (PA), so-called PA, "diffuse variant." Among 106 cerebellar low-grade astrocytomas (WHO grade I and II) operated on at the Mayo Clinic (1984-2010), we identified 19 such cases: 8 PA, "diffuse variant," 5 DA, and 6 that we were unable to classify further (low-grade astrocytomas, subtype indeterminate). We characterized these tumors using immunohistochemistry and currently available molecular markers (IDH1/2 mutations and BRAF mutation/fusion gene status) and investigated whether the markers could be used to aid the diagnostic process in combination with the clinical and pathologic features. KIAA1549-BRAF fusion was detected in 4 PA, "diffuse variant," 2 DA, and 2 low-grade astrocytomas, subtype indeterminate, indicating that these tumors were molecularly consistent with PA, the most common subtype of the series. A BRAF V600E mutation was detected in 1 PA, "diffuse variant" case; an IDH1 R132G mutation was found in 1 DA case. These results suggest that KIAA1549-BRAF fusion status and IDH1/2 and BRAF V600E mutational analyses may assist in the histologic classification of this diagnostically challenging group of tumors and result in a more accurate and objective combined molecular and histologic classification.

KW - BRAF

KW - Cerebellar astrocytoma

KW - Diffuse

KW - IDH1

KW - IDH2

KW - Low grade

KW - Pilocytic

UR - http://www.scopus.com/inward/record.url?scp=84862840727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862840727&partnerID=8YFLogxK

U2 - 10.1097/NEN.0b013e31825c448a

DO - 10.1097/NEN.0b013e31825c448a

M3 - Article

C2 - 22710963

AN - SCOPUS:84862840727

VL - 71

SP - 631

EP - 639

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 7

ER -